Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein

AUTOR(ES)

Taylor, J. Paul

FONTE

Cold Spring Harbor Laboratory Press

RESUMO

Sequestration of the transcriptional coactivator CREB-binding protein (CBP), a histone acetyltransferase, has been implicated in the pathogenesis of polyglutamine expansion neurodegenerative disease. We used a Drosophila model to demonstrate that polyglutamine-induced neurodegeneration is accompanied by a defect in histone acetylation and a substantial alteration in the transcription profile. Furthermore, we demonstrate complete functional and morphological rescue by up-regulation of endogenous Drosophila CBP (dCBP). Rescue of the degenerative phenotype is associated with eradication of polyglutamine aggregates, recovery of histone acetylation, and normalization of the transcription profile. These findings suggest that histone acetylation is an early target of polyglutamine toxicity and indicate that transcriptional dysregulation is an important part of the pathogenesis of polyglutamine-induced neurodegeneration.

Documentos Relacionados

• The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
• Prothymosin α interacts with the CREB-binding protein and potentiates transcription
• CREB-binding protein/p300 are transcriptional coactivators of p65
• CREB-binding protein in androgen receptor-mediated signaling
• Cubitus interruptus Requires Drosophila CREB-Binding Protein To Activate wingless Expression in the Drosophila Embryo